BN trades 34.2% below Wall Street's consensus target of $58.75.
Last 12 months price action with 12-month analyst target path
The base valuation assumes BN achieves its forward estimates and maintains a stable P/E multiple of 16.1x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Brookfield Corporation (BN) has a Wall Street consensus price target of $58.75, based on estimates from 9 covering analysts. With the stock currently trading at $43.79, this represents a potential upside of +34.2%. The company has a market capitalization of $97.96B.
Analyst price targets range from a low of $53.00 to a high of $61.00, representing a 14% spread in expectations. The median target of $60.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 8 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, BN trades at a trailing P/E of 87.6x and forward P/E of 16.1x. Analysts expect EPS to grow +383.2% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $49.65, with bear and bull scenarios of $31.28 and $65.42 respectively. Model confidence stands at 49/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
BXBlackstone Inc. | $94.7B | $120.88 | $156.29 | +29.3% | Buy | 20.5x | 29 |
KKRKKR & Co. Inc. | $85.4B | $95.14 | $141.14 | +48.3% | Buy | 15.6x | 27 |
APOApollo Global Management, Inc. | $68.8B | $119.33 | $153.50 | +28.6% | Buy | 13.4x | 28 |
CGThe Carlyle Group Inc. | $15.9B | $44.01 | $61.00 | +38.6% | Buy | 11.0x | 25 |
ARESAres Management Corporation | $39.6B | $120.70 | $171.13 | +41.8% | Buy | 20.1x | 22 |
BAMBrookfield Asset Management Ltd. | $76.3B | $46.57 | $58.44 | +25.5% | Buy | 26.2x | 20 |
BEPBrookfield Renewable Partners L.P. | $10.0B | $32.93 | $36.67 | +11.4% | Buy | — | 20 |
BIPBrookfield Infrastructure Partners L.P. | $17.0B | $36.86 | $46.00 | +24.8% | Buy | 29.8x | 17 |
BIPCBrookfield Infrastructure Corporation | $4.7B | $39.02 | $57.00 | +46.1% | Buy | 300.2x | 2 |
BEPCBrookfield Renewable Corporation | $5.2B | $35.41 | $36.00 | +1.7% | Buy | — | 4 |
Quick answers to the most common questions about buying BN stock.
The consensus Wall Street price target for BN is $58.75, representing 34.2% upside from the current price of $43.79. With 9 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
BN has a consensus rating of "Buy" based on 9 Wall Street analysts. The rating breakdown is predominantly bullish, with 8 Buy/Strong Buy ratings. The consensus 12-month price target of $58.75 implies 34.2% upside from current levels.
With a forward P/E of 16.0739x, BN trades at a relatively low valuation. The consensus target of $58.75 implies 34.2% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $61 for BN, while the most conservative target is $53. The consensus of $58.75 represents the median expectation. Our quantitative valuation model projects a bull case target of $65 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
BN is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 8 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month BN stock forecast based on 9 Wall Street analysts shows a consensus price target of $58.75, with estimates ranging from $53 (bear case) to $61 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $50, with bear/bull scenarios of $31/$65.
Our quantitative valuation model calculates BN's fair value at $50 (base case), with a bear case of $31 and bull case of $65. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 49/100.
BN trades at a forward P/E ratio of 16.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 87.6x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on BN, with a "Buy" consensus rating and $58.75 price target (34.2% upside). 8 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
BN analyst price targets range from $53 to $61, a 14% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $58.75 consensus represents the middle ground. Our model's $31-$65 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.